Kolle S, Mørkve O
Diakonissehjemmets Sykehus Haraldsplass, Instituttet medisinsk avdeling A Universitetet i Bergen.
Tidsskr Nor Laegeforen. 1998 Sep 10;118(21):3268-71.
Obstructive pulmonary disease can be divided into bronchial asthma and chronic obstructive pulmonary disease. Using a questionnaire, we carried out a survey among doctors in Hordaland county in order to discover how they diagnosed and treated obstructive pulmonary disease. The response rate was 60%; 119 general practitioners and 48 hospital doctors. In spite of recommended guidelines, 20% of the doctors did not perform any kind of spirometry when diagnosing obstructive pulmonary disease. Spirometry after inhalation of bronchodilators or corticosteroids was performed by 29% of the doctors when diagnosing chronic obstructive pulmonary disease and by 43% when diagnosing asthma. 88% of the doctors who participated in our survey preferred to treat asthma with inhalation of beta-agonist or inhalation of corticosteroids, or both. This was in accordance with recommended guidelines. There was greater uncertainty amongst the doctors concerning the treating of chronic obstructive pulmonary disease, and the guidelines were followed to a lesser extent.
阻塞性肺疾病可分为支气管哮喘和慢性阻塞性肺疾病。我们通过问卷调查对霍达兰郡的医生进行了一项调查,以了解他们如何诊断和治疗阻塞性肺疾病。回复率为60%;有119名全科医生和48名医院医生。尽管有推荐的指南,但20%的医生在诊断阻塞性肺疾病时未进行任何形式的肺功能测定。29%的医生在诊断慢性阻塞性肺疾病时以及43%的医生在诊断哮喘时会在吸入支气管扩张剂或皮质类固醇后进行肺功能测定。参与我们调查的医生中,88%更倾向于使用吸入β受体激动剂或吸入皮质类固醇,或两者兼用来治疗哮喘。这与推荐指南一致。医生们在治疗慢性阻塞性肺疾病方面存在更大的不确定性,对指南的遵循程度较低。